Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Exosome Sciences, Inc.
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Outside Media

Press Releases

Apr 17, 2019

Aethlon Medical Releases Shareholder Update

Mar 7, 2019

Aethlon Medical, Inc. Announces Appointment of Lisa M. Boswell as Director, Quality Systems and Regulatory Affairs

Feb 11, 2019

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Feb 4, 2019

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on February 11, 2019

Dec 13, 2018

Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer

Nov 27, 2018

Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration

Nov 6, 2018

Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results

Nov 1, 2018

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018

Oct 29, 2018

Aethlon Medical to Present at the NYC Oncology Conference

Oct 16, 2018

Aethlon Medical to Present at the 2018 BIO Investor Forum

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...19
    • Facebook
    • Twitter
    • Linkedin
    • YouTube
    Privacy Policy Disclaimer Sitemap
    © 2021 Aethlon Medical, Inc. All Rights Reserved.